-
CheckOrphan NewsFlash April 30,…
4/30/2010
CheckOrphan NewsFlash for Tuesday, March 30, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
-
CheckOrphan NewsFlash April 9,…
4/09/2010
CheckOrphan NewsFlash for Friday, April 9, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and…
-
CheckOrphan NewsFlash April 1,…
4/01/2010
CheckOrphan NewsFlash for Thursday, April 1, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
NewsFlash
-
8th Annual Encephalitis Conference
Monday, 16 August, 2010
Encephalitis Global, Inc. is happy to invite FACES (Friends And Caregivers…
-
David W. Smith Workshop on…
27 August – 1 September, 2010
The goal of the Smith Workshop is to bring together a diverse group of…
-
The 15th International Symposium…
29 August – 1 September, 2010
Studies on the sinusoidal cells are becoming increasingly important in…
-
Immunotherapy in Pediatric…
9–10 September, 2010
Goals of this conference are to (1) enhance collaboration and cross-…
Events
Friday, July 30, 2010Drug Resistance Threatens New Sleeping Sickness CureCape Town -- Hopes for an effective new combination treatment for sleeping sickness have been challenged by the discovery of resistance to two of the drugsSleeping sickness, or human African trypanosomiasis, is one of Africa's most deadly and neglected diseases, transmitted by the bite of the tset More … |
Friday, July 30, 2010
|
Friday, July 30, 2010UCLA Scientists for the First Time Identify a Cell-of-Origin for…UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the diseaseThe researchers, from UCLA's Jonsson Comprehensiv More … |
Friday, July 30, 2010
|
Friday, July 30, 2010Notre Dame Professor Receives $1.9 Million Grant for TB ResearchSOUTH BEND -- Marvin Miller, a chemistry professor at the University of Notre Dame, has received a $1.9 million grant from the National Institutes of Health for tuberculosis researchMiller and his research group aim to understand TB's essential iron sequestration machinery and develop novel anti-T More … |
Friday, July 30, 2010
|
Groups |
||








